In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

Ozempic is available in India but may not be as widely accessible as in other countries. Keep reading as we answer some FAQs ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Australia is home to some truly unique and unexpected creatures, but few are quite as strange and fascinating as the platypus ...

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

Eli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

Investors, startups and insurers are promoting individual coverage health reimbursement arrangements, known as ICHRAs, even ...

BMI falls short as a way to measure obesity. Doctors need to also determine whether body fat harms a person's health.

Hanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press ...